Disease Overview：Migraine（MIG）
Migraine is a prevalent, disabling primary headache disorder characterized by recurrent, moderate-to-severe unilateral or bilateral throbbing headaches, often accompanied by nausea, vomiting, photophobia, and phonophobia. Attacks typically last 4–72 hours and may be preceded by prodromal symptoms or aura—transient neurological phenomena such as visual scotoma or sensory disturbances—reflecting cortical spreading depression. Pathophysiologically, migraine involves trigeminovascular activation, neuroinflammatory cascades, and central sensitization, with strong genetic and environmental contributors. Diagnosis relies on clinical criteria per the International Classification of Headache Disorders (ICHD-3), supplemented by neuroimaging when secondary causes are suspected. Management encompasses acute pharmacotherapy (triptans, gepants, ditans), preventive strategies—including CGRP monoclonal antibodies and neuromodulation devices—and lifestyle optimization.
China offers distinct advantages for international patients seeking advanced migraine care. Leading neurology centers in Beijing, Shanghai, and Guangzhou house multidisciplinary headache clinics staffed by specialists trained in both Western and integrative approaches, with extensive experience managing refractory cases. State-of-the-art facilities feature high-field MRI, quantitative EEG, and non-invasive brain stimulation platforms (e.g., rTMS, tDCS) validated in peer-reviewed studies. Clinical outcomes align with global benchmarks: over 70% of chronic migraine patients achieve ≥50% reduction in headache days after personalized CGRP-targeted regimens. Crucially, treatment costs in China are typically 40–60% lower than in the US or Western Europe—without compromising evidence-based protocols or regulatory oversight (NMPA-approved biologics, ISO-certified hospitals).
As a dedicated medical tourism agency, we streamline access to this high-value care: verifying hospital credentials, coordinating specialist consultations, providing itemized, transparent pricing in advance, arranging visas and accommodations, and offering bilingual clinical liaison support throughout diagnosis, treatment, and follow-up—ensuring continuity, clarity, and confidence for every patient.
Migraine: treatment in China helps patients compare specialist hospitals, initial assessment steps and estimated costs that may vary by city, institution and clinical condition.
Medical Treatment Guide
Treatment Options & Itemized Cost Breakdown: Migraine (Neurology Department)
Non-Surgical / Conservative / Medication Options
*Target Criteria:* Episodic (≤14 days/month) or chronic migraine (≥15 days/month, ≥8 with migraine features); no contraindications to pharmacotherapy.
- •Acute Abortive Therapy
- *Ubrogepant 50 mg tablet*: ¥198–¥225 ($28–$32) per dose; max 8 doses/month - *IV Metoclopramide + Dexamethasone (ER)*: ¥120–¥150 ($17–$21) per infusion
- •Preventive Pharmacotherapy
- *Propranolol (40–120 mg/day)*: ¥12–¥20 ($1.7–$2.9) monthly - *Fremanezumab (224 mg SC injection, monthly)*: ¥2,850–¥3,100 ($405–$440) per dose - *Galcanezumab (120 mg SC, monthly)*: ¥2,680–¥2,920 ($380–$415) per dose
- •Diagnostic & Monitoring Fees (Neurology Dept.)
- *EEG (routine, 30-min)*: ¥220 ($31) - *Brain MRI (1.5T, without contrast)*: ¥780–¥920 ($110–$130) - *Serum magnesium/calcium/vitamin D testing*: ¥180–¥240 ($25–$34)
Surgical / Procedural / Interventional Options
*Eligibility Criteria:* Chronic migraine refractory to ≥3 preventive drug classes + ≥3 abortive agents; confirmed trigger points on physical exam; negative structural MRI; no psychiatric instability.
- •OnabotulinumtoxinA (Botox®) Injection (FDA/CFDA-approved for chronic migraine)
- *Pre-op workup (neurological exam + EMG-trigger point mapping)*: ¥360 ($51)
- •Greater Occipital Nerve Block (Ultrasound-guided)
- *Pre-op: Cervical spine X-ray (AP/lateral)*: ¥140 ($20)
Special / Complex Condition Options
- •*Migraine with Persistent Aura or Status Migrainosus*: IV valproate infusion (¥420–¥510/$60–$72) + ICU neurology monitoring (¥1,800–¥2,400/$255–$340/day).
- •*Medication Overuse Headache (MOH)*: Structured withdrawal protocol (7-day inpatient detox): ¥6,500–¥8,200 ($920–$1,160), includes neurology consults, IV hydration, and behavioral counseling.
Quick Selection Guide
- •<18 years, mild episodic: Start with propranolol + lifestyle coaching — total first-year cost: ~$120
- •35–55 years, chronic, moderate budget: Fremanezumab + Botox® (alternating cycles) — annual cost: $4,200–$4,800
- •>60 years, comorbid hypertension/diabetes: Topiramate + occipital nerve block — annual cost: $680–$850
- •Refactory MOH: Inpatient detox + cognitive behavioral therapy — one-time cost: $1,050–$1,250
- •Low-income, episodic: Rizatriptan + EEG + neurology follow-up — first-year cost: $185–$220
Pricing & Service Differences: International / VIP Dept vs. Regular Clinic
International Medical Services (IMS / VIP Departments) at Grade-3A public hospitals and private international clinics operate under self-regulated VIP fee schedules. Fees are higher than standard public clinics (which are subsidized solely for domestic citizens and do not accept overseas insurances). In exchange, international patients receive 6 exclusive medical privileges:
Recommended Hospitals
Explore selected Grade 3A public hospitals in China with rich clinical experience for this condition:
🌴 Recommended Migraine Medical Vacation Packages
Curated transparent all-inclusive packages combining Migraine treatment with China top medical destinations:
